|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.90 NOK | +0.87% |
|
-4.93% | -18.91% |
| 06-09 | Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics | MT |
| 06-08 | Photocure ASA and Artera Partner on Digital Pathology AI Test Evaluation for Bladder Cancer | CI |
Company Valuation: Photocure ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,769 | 2,895 | 1,827 | 1,681 | 1,900 | 1,527 | - | - |
| Change | - | 4.55% | -36.89% | -8.01% | 13.04% | -19.61% | - | - |
| Enterprise Value (EV) 1 | 2,483 | 2,639 | 1,567 | 1,387 | 1,661 | 1,204 | 1,162 | 1,115 |
| Change | - | 6.28% | -40.61% | -11.53% | 19.77% | -27.49% | -3.49% | -4.04% |
| P/E Ratio | -89.3x | -40.2x | 6,740x | -344x | -1,190x | 18.8x | 30x | 30.9x |
| PBR | - | - | - | - | - | 2.67x | 2.36x | 2.27x |
| PEG | - | -0x | -67x | 0x | 17.9x | -0x | -0.8x | -9.86x |
| Capitalization / Revenue | 7.68x | 7.73x | 4.09x | 3.42x | 3.57x | 2.41x | 2.26x | 2.14x |
| EV / Revenue | 6.89x | 7.05x | 3.51x | 2.82x | 3.12x | 1.9x | 1.72x | 1.56x |
| EV / EBITDA | 136x | -107x | 28.2x | 28.2x | 57.8x | 12.7x | 11x | 10.9x |
| EV / EBIT | -426x | -53.9x | 56.4x | 68x | -2,229x | 14.4x | 12.2x | 12.1x |
| EV / FCF | 113x | -469x | 35.4x | 18.4x | 95x | 11.9x | 33.2x | 28.6x |
| FCF Yield | 0.89% | -0.21% | 2.82% | 5.43% | 1.05% | 8.43% | 3.01% | 3.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.15 | -2.66 | 0.01 | -0.18 | -0.06 | 3.05 | 1.915 | 1.855 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 360.5 | 374.5 | 446.2 | 491.7 | 532.6 | 634.5 | 675.5 | 714 |
| EBITDA 1 | 18.3 | -24.63 | 55.49 | 49.19 | 28.73 | 94.5 | 105.5 | 102 |
| EBIT 1 | -5.826 | -49 | 27.81 | 20.4 | -0.745 | 83.5 | 95 | 92 |
| Net income 1 | -30.9 | -71.86 | 0.267 | -4.81 | -1.519 | 81.5 | 51 | 49.5 |
| Net Debt 1 | -285.4 | -255.6 | -259.5 | -293.9 | -238.9 | -323 | -365 | -412 |
| Reference price 2 | 102.70 | 106.80 | 67.40 | 62.00 | 71.40 | 57.40 | 57.40 | 57.40 |
| Nbr of stocks (in thousands) | 26,960 | 27,106 | 27,106 | 27,106 | 26,607 | 26,607 | - | - |
| Announcement Date | 2/23/22 | 2/23/23 | 2/21/24 | 2/19/25 | 2/18/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.82x | 1.9x | 12.74x | - | 161M | |
| 33.25x | 12.09x | 24.89x | 0.6% | 1,013B | |
| 25.49x | 5.87x | 15.97x | 2.24% | 574B | |
| 27.54x | 6.71x | 13.71x | 3.05% | 397B | |
| 17.38x | 4.29x | 10.55x | 3.1% | 324B | |
| 22.74x | 4.73x | 13.45x | 1.85% | 280B | |
| 20.72x | 5.35x | 13x | 3.04% | 273B | |
| 21.96x | 5.91x | 10.33x | 2.99% | 182B | |
| 12.52x | 4.69x | 9.6x | 4.01% | 194B | |
| -43.47x | 5.27x | 29.72x | 2.67% | 151B | |
| Average | 15.69x | 5.68x | 15.40x | 2.62% | 338.88B | |
| Weighted average by Cap. | 22.66x | 7.45x | 17.35x | 2.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PHO Stock
- Valuation Photocure ASA
Select your edition
All financial news and data tailored to specific country editions
